dc.creator | Bix, Gregory J. | |
dc.date.accessioned | 2019-06-17T17:07:32Z | |
dc.date.available | 2019-06-17T17:07:32Z | |
dc.date.issued | 2013-06-18 | |
dc.identifier.uri | https://hdl.handle.net/1969.1/177033 | |
dc.description.abstract | The present invention is drawn to methods of stimulating or enhancing angiogenesis in a patient comprising, administering to said patient a therapeutically effective amount of an endorepellin protein, wherein said endorepellin protein has an amino acid sequence of domain V of perlecan or fragments or derivatives, analogs thereof; and stimulating or enhancing generation of blood vessels. The present invention is drawn to compositions for enhancing angiogenesis. | en |
dc.language | eng | |
dc.publisher | United States. Patent and Trademark Office | |
dc.rights | Public Domain (No copyright - United States) | en |
dc.rights.uri | http://rightsstatements.org/vocab/NoC-US/1.0/ | |
dc.title | Treatment of stroke using domain V of perlecan | en |
dc.type | Utility patent | en |
dc.format.digitalOrigin | reformatted digital | en |
dc.description.country | US | |
dc.contributor.assignee | The Texas A&M University System | |
dc.identifier.patentapplicationnumber | 12/655503 | |
dc.subject.uspcprimary | 514/13.3 | |
dc.subject.uspcother | 514/9.6 | |
dc.subject.uspcother | 514/54 | |
dc.subject.uspcother | 530/350 | |
dc.subject.uspcother | 530/380 | |
dc.date.filed | 2009-12-31 | |
dc.publisher.digital | Texas A&M University. Libraries | |
dc.subject.cpcprimary | A61K 38/1709 | |
dc.subject.cpcprimary | C07K 14/4725 | |
dc.subject.cpcprimary | A61K 45/06 | |
dc.subject.cpcprimary | C07K 14/7055 | |
dc.subject.cpcprimary | A61P 9/00 | |
dc.subject.cpcprimary | C07K 14/705 | |
dc.subject.cpcprimary | A61P 25/00 | |
dc.subject.cpcprimary | A61P 9/10 | |
dc.subject.cpcprimary | C07K 14/78 | |
dc.subject.cpcprimary | A61K 38/1709 | |
dc.subject.cpcprimary | A61K 2300/00 | |